New eye drop shows promise for glaucoma in early trial
Disease control
Completed
This study tested a new eye drop called SBI-100 to see if it could safely lower high pressure inside the eye, which is a key factor in glaucoma. 56 adults with glaucoma or high eye pressure were randomly assigned to use one of two strengths of the eye drop or a placebo drop twice…
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC